Effects of dietary changes on food choices and brain function
Official title: "SFB 1052/3 - Mechanismen Der Adipositas, Projekt A1: Veränderung Der Neurobiologischen Grundlagen Von Ess-Entscheidungen Bei Adipositas" Engl. "CRC 1052/3 - Obesity Mechanisms, Project A1: Targeting Neurobehavioral Determinants of Obesity"
Run by Max Planck Institute for Human Cognitive and Brain Sciences · NCT05353504 · Data updated 2026-11-12
This study is testing if changing diets can help overweight and obese adults make better food choices and improve their brain function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Max Planck Institute for Human Cognitive and Brain Sciences Academic / other |
| Locations | 1 site (Leipzig) |
| Status | Recruiting |
| Started | March 8, 2022 |
| Main results expected | December 2024 |
| Study ends | December 2026 |
| Registry record updated | April 29, 2022 |
| Trial ID | NCT05353504 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are overweight or obese adults with a BMI of 25 kg/m2 or higher.
✕Probably not a fit
Patients with clinically relevant psychiatric diseases, chronic inflammatory or malignant diseases, or those who have undergone bariatric surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates how dietary interventions that alter the gut microbiome can influence food decision-making in overweight and obese adults. A total of 90 participants will be randomly assigned to receive either a pre-biotic dietary intervention, a behavioral lifestyle intervention, or a control condition over 26 weeks. The study will utilize functional and structural MRI, cognitive testing, and microbiota analysis through stool samples to assess changes in brain function and gut health. The goal is to understand the mechanisms behind how diet impacts food choices and overall health.
Why it matters
Potential benefit: If successful, this study could lead to new dietary strategies that improve food decision-making and aid in weight management for individuals with obesity.
How similar studies have gone: While the specific approach of this study may be novel, previous research has shown promising results in the relationship between gut microbiota and dietary interventions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI \>= 25 kg/m2 or WHR \>= 0.9/0.85 (m/d, f) * no MRI contra-indication * written informed consent Exclusion Criteria: * athletes * occurrence of a clinically relevant psychiatric disease in the last 12 months, e.g. depression, substance abuse, eating disorders, schizophrenia * any chronic inflammatory or malignant disease * type 1 diabetes * previous bariatric/gastric surgery * pregnancy or breastfeeding woman
Where it's running
-
Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences
Leipzig, Germany Recruiting
Study contacts
- Principal investigator: Veronica Witte, PhD — Cognitive Neurology, University Medical Center Leipzig
- Study coordinator: Meghedi Vartanian, MSc
- Email: mi-food@cbs.mpg.de
- Phone: +49(0)341/9940-951
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nutrition support to improve dietary diversity in adults who are underweight or overweight/obese
A community-based nutrition program will be tested in adults in Cambodia to see if it improves dietary diversity and if the program is acceptable and feasible to run.
-
Hesperidin for better thinking in overweight older adults
In adults aged 55–75 who are overweight, taking hesperidin or a placebo for 10 weeks will show whether the citrus flavonoid can improve thinking skills like memory, attention, and problem-solving.
-
MR-based performance tests for overweight and obesity
This study tests mixed reality versions of mobility tests to see if they match conventional assessments in adults who are overweight or obese.
-
DA-302168S in adults with overweight or obesity
A phase 3 trial in China is testing whether DA-302168S helps people who are overweight or obese lose weight compared with a placebo.
-
Metabolic Health Trajectories in Overweight Chinese Adults
This observational study follows overweight and obese Chinese adults to see how metabolic health changes over five years and whether people stay healthy, develop diabetes, or have complications.
-
Blood-count inflammation scores (SII and SIRI) to predict metabolic complications in adults with overweight or obesity
This project will test whether two blood-count-based scores (SII and SIRI) can help predict metabolic complications and treatment response in adults with overweight or obesity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.